Contact us for a demo Follow us:
New leadership, shared ambition
Nearly six years ago, we joined the Ypso-Facto journey, eager to contribute and learn from a company driven by science and innovation. What we found exceeded our expectations: a unique environment, remarkable people, and exciting challenges at the crossroads of chemistry, biology, and process...Time flies like an arrow…
40 years have gone by since I graduated, 30 years since I created Novasep and 10 years since I created Ypso-Facto. At Ypso-Facto, during the last years we built simulation-based software taking the difficult path of mechanistic modeling. No matter the challenges, we have stayed true to our...
Bioprocess Development Symposium Celebrating Ypso-Facto’s 10th Anniversary
2-3 October 2024, Nancy
On October 2-3 2024, Ypso-Facto marked a significant milestone by hosting the Bioprocess Development Symposium in celebration of its 10th anniversary. This two-day event, held in Nancy, France, brought together industry leaders and innovators to explore the cutting edge of bioprocessing. The...
Ypso-Facto are pleased to announce that they got granted three families of patents
Ypso-Facto are pleased to announce that they got granted three families of patents in the last months: Method and device for simulating an industrial facility for exploiting a chemical or biochemical method EP 3 566 769 B1 System and method for simulating chemical or biochemical process EP...Ypso-Facto cooperates with SmarSEP Industries to provide process modeling and numerical simulation services for the Chinese Industrial Biotechnology Market.
Ypso-Facto® (Nancy, France), a leading provider of (bio)chemical process simulation software and services, has announced a cooperation agreement with Shanghai- based SmarSEP Industries to provide process modeling and numerical simulation services for the Chinese Industrial Biotechnology...
Ypso-Facto officially joins the ACCESS project
Ypso-Facto is proud to join officially the ACCESS project (Advanced Cell Control by Spectroscopic Sensors), a French R&D project aiming at improving the production of Advanced Therapy Medicinal products. This project is led by INDATECH – Chauvin Arnoux group, gathers MTInov, StemInov, Ondalys,...
PRESS RELEASE : Ypso-Facto is part of the CALIPSO project led by Sanofi, to disrupt the production of biomedicines!
Supported by Bpifrance, the CALIPSO project aims at developing a new generation of tools that will disrupt industrial bioproduction processes.
Nancy, France, 16 Sept 2021 - Ypso-Facto is proud to play a major role in this challenging and exciting project. With its expertise in bioprocesses and predictive simulation, Ypso-Facto will develop software solutions to support production of innovative therapies. The company will work on three...
CALIPSO: revolutionizing the management of bioproduction processes in healthcare
Paris (France) – September 16th, 2021 – Sanofi, Capgemini, Ypso-Facto, GPC Bio, CEA, CentralSupelec announce the launch of the project CALIPSO !
A structuring R&D project for French medical research, financed and coordinated by a consortium of high-profile industrial and public actors. An essential mobilisation to accelerate access to new treatments at an acceptable cost, to ensure France’s competitiveness and its health...
Ypso-Facto is a service company helping industrial firms to develop, optimize and secure their chemical processes and bioprocesses.
© Ypso-Facto 2014 - Powered by Ealys | Legal Information